Cancer Discovery

Published by: American Association for Cancer Research  

People

  1. Drilon
    Drilon
  2. Ladanyi
    Ladanyi
  3. Berger
    Berger
  4. Ginsberg
    Ginsberg
  5. Kris
    Kris
  6. Rudin
    Rudin
  7. De Stanchina
    De Stanchina
  8. Plodkowski
    Plodkowski
  9. Rekhtman
    Rekhtman
  10. Riely
    Riely

Groups

  1. Body Imaging Service (12)
  2. Radiology, Department of (12)
  3. Department of Medicine (11)
  4. Solid Tumor Oncology Division (11)
  5. Department of Pathology and Laboratory Medicine (10)
  6. GSK Faculty (10)
  7. Human Oncology and Pathogenesis Program (8)
  8. Sloan Kettering Institute Postdocs (7)
  9. Thoracic Oncology (7)
  10. Tow Center for Developmental Oncology (TCDO) (7)
Search Within
  1. "Body Imaging Service"
Formats
  1. Journal Article (12)
Groups
  1. Body Imaging Service (12)
  2. Radiology, Department of (12)
  3. Department of Medicine (11)
  4. Solid Tumor Oncology Division (11)
  5. Department of Pathology and Laboratory Medicine (10)
  6. GSK Faculty (10)

More Groups

People
  1. Alexander Drilon (5)
  2. Marc Ladanyi (5)
  3. Charles Rudin (4)
  4. Mark Kris (4)
  5. Michael Berger (4)
  6. Michelle Ginsberg (4)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2019 (2)
  4. 2018 (3)
  5. 2017 (1)
  6. 2015 (1)

More Years

Publishers
  1. American Association for Cancer Research (12)

Results (12)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zenocutuzumab, a HER2XHER3 bispecific antibody, is effective therapy for tumors driven by NRG1 gene rearrangements
    Journal Article

    Schram, A. M.; Odintsov, I.; Espinosa-Cotton, M.; Khodos, I.; Sisso, W. J.; Mattar, M. S.; Lui, A. J. W.; Vojnic, M.; Shameem, S. H.; Chauhan, T.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders
    Journal Article

    Kornauth, C.; Pemovska, T.; Vladimer, G. I.; Bayer, G.; Bergmann, M.; Eder, S.; Eichner, R.; Erl, M.; Esterbauer, H.; Exner, R.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Deep learning to estimate RECIST in patients with NSCLC treated with PD-1 blockade
    Journal Article

    Arbour, K. C.; Luu, A. T.; Luo, J.; Rizvi, H.; Plodkowski, A. J.; Sakhi, M.; Huang, K. B.; Digumarthy, S. R.; Ginsberg, M. S.; Girshman, J.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • V211D mutation in MEK1 causes resistance to MEK inhibitors in colon cancer
    Journal Article

    Gao, Y.; Maria, A.; Na, N.; da Cruz Paula, A.; Gorelick, A. N.; Hechtman, J. F.; Carson, J.; Lefkowitz, R. A.; Weigelt, B.; Taylor, B. S.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition
    Journal Article

    Harding, J. J.; Lowery, M. A.; Shih, A. H.; Schvartzman, J. M.; Hou, S.; Famulare, C.; Patel, M.; Roshal, M.; Do, R. K.; Zehir, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • STK11/LKB1 mutations and PD-1 inhibitor resistance in KRAS-mutant lung adenocarcinoma
    Journal Article

    Skoulidis, F.; Goldberg, M. E.; Greenawalt, D. M.; Hellmann, M. D.; Awad, M. M.; Gainor, J. F.; Schrock, A. B.; Hartmaier, R. J.; Trabucco, S. E.; Gay, L.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Response to ERBB3-directed targeted therapy in NRG1-rearranged cancers
    Journal Article

    Drilon, A.; Somwar, R.; Mangatt, B. P.; Edgren, H.; Desmeules, P.; Ruusulehto, A.; Smith, R. S.; Delasos, L.; Vojnic, M.; Plodkowski, A. J.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies
    Journal Article

    Jordan, E. J.; Kim, H. R.; Arcila, M. E.; Barron, D.; Chakravarty, D.; Gao, J. J.; Chang, M. T.; Ni, A.; Kundra, R.; Jonsson, P.; more...
    Cancer Discovery (2017)

    Fulltext@MSK | Save
  • Response to MET inhibitors in patients with stage IV lung adenocarcinomas harboring met mutations causing exon 14 skipping
    Journal Article

    Paik, P. K.; Drilon, A.; Fan, P. D.; Yu, H.; Rekhtman, N.; Ginsberg, M. S.; Borsu, L.; Schultz, N.; Berger, M. F.; Rudin, C. M.; more...
    Cancer Discovery (2015)

    Fulltext@MSK | Save

    • Cancer Discovery – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 Unknown
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598290 American Association for Cancer Research
    Cancer discovery 21598290 The Authors the American Association for Cancer Research
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer discovery 21598290 American Association for Cancer Research
    Cancer Discovery 2159-8290 American Association for Cancer Research
    Cancer Discovery 2159-8274 American Association for Cancer Research
    Cancer discovery 2159-8290 American Association for Cancer Research
    Cancer Discovery 21598274 Unknown
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598274 American Association for Cancer Research
    Cancer Discovery 21598274 The Authors
    Cancer Discovery 21598274 The Authors the American Association for Cancer Research
    Cancer Discovery 21598274 The Authors the American As Sociation for Cancer Research
    Cancer discovery 21598290 Unknown